Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-17

Clinical Trial Update: The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Atorva 20 mg with Lipitor 20 mg in hypercholesterolemia to evaluate relative efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atorva (atorvastatin)
  • Lipitor (atorvastatin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED